Search results for "Highlights"
ACP releases its 2021-2022 Annual Report of the Executive Vice President
The report highlights ACP news and activities over the past year.
https://immattersacp.org/weekly/archives/2022/07/05/1.htm
5 Jul 2022
Nonopioids effective for acute low back pain, review finds
Myorelaxants and NSAIDs with or without acetaminophen were all effective at reducing pain and disability from acute, nonspecific low back pain lasting less than 12 weeks, according to an analysis of 18 randomized controlled trials, although the authors stressed that medications for this condition should always be a second-line strategy.
https://immattersacp.org/weekly/archives/2023/02/28/1.htm
28 Feb 2023
ACP's Pain Management Learning Hub releases new learning materials
Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.
https://immattersacp.org/weekly/archives/2022/02/01/6.htm
1 Feb 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/09/latest-updates-on-acps-priorities-initiatives.htm
1 Sep 2021
New highlighting feature added to MKSAP 18 Digital and Complete versions
Users can highlight text or questions by clicking on the highlighting icon at the bottom of the screen and review highlights using the highlight index.
https://immattersacp.org/weekly/archives/2020/02/25/5.htm
25 Feb 2020
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2021
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2022
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021